[go: up one dir, main page]

Liu et al., 2016 - Google Patents

Conjugation of biotin-coated luminescent quantum dots with single domain antibody-rhizavidin fusions

Liu et al., 2016

View HTML
Document ID
14317461905586960576
Author
Liu J
Walper S
Turner K
Lee A
Medintz I
Susumu K
Oh E
Zabetakis D
Goldman E
Anderson G
Publication year
Publication venue
Biotechnology Reports

External Links

Snippet

Straightforward and effective methods are required for the bioconjugation of proteins to surfaces and particles. Previously we demonstrated that the fusion of a single domain antibody with the biotin binding molecule rhizavidin provided a facile method to coat biotin …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/536—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/531—Production of immunochemical test materials

Similar Documents

Publication Publication Date Title
Ritzefeld Sortagging: a robust and efficient chemoenzymatic ligation strategy
Djender et al. Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies
Sutherland et al. Post‐translational assembly of protein parts into complex devices by using SpyTag/SpyCatcher protein ligase
US8343727B2 (en) Method of binding proteins to carriers by making use of tamavidins
Liu et al. Conjugation of biotin-coated luminescent quantum dots with single domain antibody-rhizavidin fusions
Liao et al. Enhanced sandwich immunoassay based on bivalent nanobody as an efficient immobilization approach for foodborne pathogens detection
Rousserie et al. Detection of carcinoembryonic antigen using single-domain or full-size antibodies stained with quantum dot conjugates
CN112352055A (en) Bioluminescent biosensors for detecting and quantifying biomolecules or ligands in solution
Walper et al. Comparison of single domain antibody immobilization strategies evaluated by surface plasmon resonance
US7741128B2 (en) Cooperative reporter systems, components, and methods for analyte detection
Liu et al. Bioconjugates of rhizavidin with single domain antibodies as bifunctional immunoreagents
WO2015028550A1 (en) C5 binding polypeptides
Kimura et al. Rapid and homogeneous electrochemical detection by fabricating a high affinity bispecific antibody-enzyme complex using two Catcher/Tag systems
CN105807064B (en) A luciferase complementary quantum dot biosensor and its construction method and application
Walper et al. Thermostable single domain antibody–maltose binding protein fusion for Bacillus anthracis spore protein BclA detection
Gu et al. Development of a highly sensitive immunoassay based on pentameric nanobodies for carcinoembryonic antigen detection
Sakamoto et al. Enzyme-mediated site-specific antibody− protein modification using a zz domain as a linker
CN120173098B (en) A nanobody that specifically recognizes Staphylococcus aureus and its application
JP6873483B2 (en) Fusion protein and method for detecting antigen using it
Thammawong et al. Twin-arginine signal peptide attributes effective display of CD147 to filamentous phage
WO2021113736A1 (en) Single-domain antibody to chloramphenicol
Manoswini et al. Rapid detections of food pathogens using metal, semiconducting nanoparticles, and their hybrids: a review
US9778265B2 (en) Charged peptide appendage to facilitate oriented protein covalent immobilization
Mori et al. Zipbodyzyme: development of new antibody-enzyme fusion proteins
Dodge et al. Selection of nanobodies against liponanoparticle-embedded membrane proteins by yeast surface display